KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Novavax's Total Non-Current Liabilities fell 4411.06% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 4411.06%. This contributed to the annual value of $1.8 billion for FY2024, which is 2646.38% down from last year.
  • As of Q3 2025, Novavax's Total Non-Current Liabilities stood at $1.1 billion, which was down 4411.06% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Novavax's Total Non-Current Liabilities ranged from a high of $3.0 billion in Q2 2022 and a low of $1.0 billion during Q2 2025
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $2.1 billion (2021), whereas its average is $2.1 billion.
  • Per our database at Business Quant, Novavax's Total Non-Current Liabilities soared by 35193.33% in 2021 and then crashed by 4719.02% in 2025.
  • Novavax's Total Non-Current Liabilities (Quarter) stood at $2.9 billion in 2021, then decreased by 1.71% to $2.8 billion in 2022, then dropped by 12.54% to $2.5 billion in 2023, then decreased by 26.46% to $1.8 billion in 2024, then crashed by 41.19% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.0 billion for Q2 2025, and $1.1 billion during Q1 2025.